跳至主要内容
临床试验/NCT03093558
NCT03093558已完成不适用

Pilot Atrial Fibrillation Information Technology Trial

University of Pittsburgh2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2017年6月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
2
主要终点
Daily adherence to the Embodied Conversational Agent and Kardia heart rhythm monitor

研究概览

简要总结

AF is associated with significant social and medical costs, including diminished quality of life (QOL) and increased health care utilization (HCU). This pilot study will enroll 200 adults with prevalent, non-valvular AF of ≤3 year's duration at University of Pittsburgh Medical Center (UPMC). The primary objective at present is to obtain extensive feasibility and pilot data in implementing the Embodied Conversational Agent (ECA) in concert with the Kardia (KAC) heart rhythm monitor.

详细描述

This pilot study is a single-center, two-arm randomized study that by design is unblinded. 200 total participants are planned. Each participant will be randomized in an unblocked manner to receive "usual care" or the ECA/KAC intervention. Participants will have study visits at baseline and time 30 days. Adherence to using the ECA/KAC in combination over 30 days will be quantified. Following participation study participants randomized to the ECA/KAC intervention will undergo an interview to determine their experience with the ECA/KAC. Participants and their physicians will receive a summary of ECA use and symptoms and correlated findings by KAC.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • CHADS2-VASc score ≥2; English-speaking (at level appropriate to provide informed consent and participate in this research protocol); no plan to relocate from the area within 12 months of enrollment

排除标准

  • AF that is due to non-cardiac causes (e.g., sepsis, pneumonia, thyroid disorders, and intoxication); AF within 30 days of any cardiothoracic or thoracic surgery; Inability to complete training session with the smartphone and demonstrate use of the ECA; Inability to answer specific protocol-based questions correctly during consent.

结局指标

主要结局

Daily adherence to the Embodied Conversational Agent and Kardia heart rhythm monitor

时间窗: 30 days

Assessment of daily use of the combined ECA and Kardia heart rate/rhythm monitor

次要结局

  • Participant experience of and response to using the ECA(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jared W Magnani, MD, MSc

Associate Professor of Medicine

University of Pittsburgh

研究点 (2)

Loading locations...

相似试验